Volpara Solutions Adds Medical Imaging Veteran John Pavlidis to Board of Directors

Bolsters Commercial Team with Deep Sales and Marketing Experience in the United States and Worldwide

Research Finds Volpara Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction

Ten Abstracts Accepted for Presentation at ECR Demonstrate Value of Automated Breast Density and Analytics Data to Help Maintain Accuracy and Consistent Quality in Breast Screening

Study Published in European Journal of Radiology Demonstrates Mammography Quality and Patient Experience Could be Standardized Using Pressure

VolparaAnalytics from Volpara Solutions Used to Compare Force, Pressure, Volumetric Density and Mammographic Dose between US and Dutch Patient Populations

Study Published in Journal of the National Cancer Institute Demonstrates High Heritability of Volumetric Breast Density

Karolinska Institute Researchers use Volpara Solutions’ Volumetric Breast Density Software to Validate Genetic Relationship between Density and Breast Cancer Risk

Volpara Solutions Signs Agreement with GE Healthcare

Volpara’s Volumetric Breast Density and Quantitative Breast Imaging Solutions to Support Screening and Supplemental Breast Imaging Modalities

Research Demonstrates Value of Volpara to Help Improve Breast Cancer Risk Prediction Models and Monitor Clinical Treatment

Five Scientific Abstracts Presented at San Antonio Breast Cancer Symposium Demonstrate Benefit of VolparaDensity

Cancer Registry of Norway Expands Study of Volpara in Breast Cancer Screening Programme

Incorporating Volumetric Breast Density and Imaging Performance Analytics in Quality Assurance Studies

Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening

Volpara Highlights Study that Shows Fully-Automated Volumetric Methods are Valid Alternatives to Measure Mammographic Breast Density and Predict Breast Cancer Risk

Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates VolparaDensity across Multiple Manufacturers

Researchers: Automated Measurement of Volumetric Mammographic Density is a Promising Tool for Widespread Breast Cancer Risk Assessment

Tomosynthesis Radiation Dose Varies Between Women According To Breast Density

Research Presented at AAPM by Volpara Solutions Questions Which Women Should be Considered for Breast Screening with Tomosynthesis Based on Reported Clinical Benefits and Patient-Specific Dose

1 3 4 5 6